Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Open, Randomized, Phase II, Clinical Trial to Compare the Immunogenicity and Safety of a Booster Dose of GSK Biologicals' DTaP-IPV Vaccine (Infanrix®-IPV) Co-administered With a Booster Dose of Merck and Company's M-M-R®II, to That of Separate Injections of GSK Biologicals' DTaP Vaccine (Infanrix®), Aventis Pasteur's IPV (IPOL®) and M-M-R®II Administered as Booster Doses to Healthy Children 4 to 6 Years of Age.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00263692
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:25.902214+00:00
Published At
2016-09-15T00:00:00+00:00
Record Updated At
2016-09-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Diphtheria", "Acellular Pertussis", "Tetanus"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-09-15"
protocolSection.identificationModule.nctId
"NCT00263692"
protocolSection.identificationModule.officialTitle
"Open, Randomized, Phase II, Clinical Trial to Compare the Immunogenicity and Safety of a Booster Dose of GSK Biologicals\u0027 DTaP-IPV Vaccine (Infanrix\u00ae-IPV) Co-administered With a Booster Dose of Merck and Company\u0027s M-M-R\u00aeII, to That of Separate Injections of GSK Biologicals\u0027 DTaP Vaccine (Infanrix\u00ae), Aventis Pasteur\u0027s IPV (IPOL\u00ae) and M-M-R\u00aeII Administered as Booster Doses to Healthy Children 4 to 6 Years of Age."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Diphtheria (protocolSection.conditionsModule.conditions)
  • Acellular Pertussis (protocolSection.conditionsModule.conditions)
  • Tetanus (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.